FI Fast Break audio news: Nov. 29, 2023

The latest Food Institute news podcast discusses which food and beverage brands resonate with Gen Z consumers.

Zepbound: Latest Weapon in Weight-Loss Drug Arsenal

Eli Lilly’s Zepbound, recently approved by the FDA, is the most potent weight-loss drug yet. Could it impact the food industry? At least one expert says ‘yes.’

FI Fast Break audio news: Nov. 1, 2023

The latest Fast Break Food Institute news podcast touches on “The Ozempic Effect” on the food and beverage industry.

A Weighty Issue: Ozempic, Wegovy Versions Considered for Kids

With 17% of children ages 10 to 17 considered obese, consideration is being given to whether diabetes drugs like Ozempic should be made available to kids. Health experts have concerns.

FI Fast Break audio news: Oct. 4, 2023

This week’s Food Institute news podcast touches on the latest innovations featured at fast-food drive-thrus.

Ozempic & Other Drugs: Explaining the Weight-Loss Medication Craze

Several medications approved to treat diabetes are being used as “miracle” weight-loss drugs, and the category continues to grow.

‘Keto’ Was Most Searched Diet Plan in 2022

Americans searched for “keto diet plan” an average of 52,000 times per month last year, according to a Total Shape report.

Say ‘Hello’ to Adele’s Preferred ‘Sirtfood’ Diet

The Sirtfood Diet is regaining some prominence after Adele posted a salad recipe based on the diet, leading spectators to believe ‘sirtfoods’ may be responsible for the singer’s 100-pound weight loss. Blogger ‘The Modern Nonna’ …

Nutrition vs. Weight Loss: Consumers Shifting Away from Diet Culture

U.S. consumer attitudes about health and wellness are shifting. People have stopped focusing on diets and “can’t haves” and are instead paying attention to whole-body health and lifestyle changes they feel will be long-lasting, according …